Alternative Approaches for the Management of Huntington's Disease: A Narrative Review

Insights

Huntington's disease (HD) management is explored through alternative therapies. Music therapy, yoga, and exercise show potential in improving HD symptoms, offering supplemental options beyond current pharmacotherapy.

Area of Science:

  • Neuroscience
  • Neurology
  • Pharmacology

Background:

  • Huntington's disease (HD) is a neurodegenerative disorder causing movement, cognitive, and psychiatric issues.
  • HD involves progressive cortical degeneration, leading to varied patient symptoms.
  • Current treatments for HD psychiatric symptoms include antidepressants and antipsychotics, but no cure exists.

Approach:

  • A literature review was conducted using PubMed and Google Scholar.
  • Clinical studies focusing on ameliorating HD symptoms were identified and analyzed.
  • The review assessed the efficacy of alternative and supplemental treatment modalities.

Key Points:

  • Alternative therapies like music therapy, video games, yoga, physical therapy, and exercise programs were investigated.
  • These non-pharmacological approaches demonstrate potential in managing various HD symptoms.
  • The heterogeneity of HD necessitates exploring diverse therapeutic strategies.

Conclusions:

  • Supplemental and alternative approaches offer promising avenues for managing Huntington's disease.
  • Music therapy, exercise, and yoga may help improve HD symptoms.
  • Further research into these modalities is crucial to fill the gap in effective HD pharmacotherapy.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
200
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
47
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
11